Use of Beta-Blockers as a First-Line Treatment for Primary Hypertension
<i>Background</i>: Even though beta-blockers had been used as a first-line therapy for hypertension, since the late 1960s, the Eighth Joint National Committee, JNC 8, decided to recommend them no longer. This decision was based on relatively weak evidence from previous studies, which fou...
Saved in:
Main Authors: | Maryam Izadi, Shiva Shafabakhsh, Amir Mirnateghi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-10-01
|
Series: | Hearts |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-3846/5/4/33 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Examining the therapeutic landscape of beta-blockers in portal hypertension
by: Anna Brujats, et al.
Published: (2024-10-01) -
Association between beta‐blocker atenolol use and prostate cancer upgrading in active surveillance1
by: Ali H. Zahalka, et al.
Published: (2024-11-01) -
Trial watch: beta-blockers in cancer therapy
by: Killian Carnet Le Provost, et al.
Published: (2023-12-01) -
Disorders of the central nervous system cognitive and mnestic functions in genetic arterial hypertension and with the use of beta-blockers of different generations
by: A. O. Svitlytskyi, et al.
Published: (2024-09-01) -
Impact of noradrenergic inhibition on neuroinflammation and pathophysiology in mouse models of Alzheimer’s disease
by: Andrew K. Evans, et al.
Published: (2024-12-01)